News
LEEF Brands Reports Q1 2026 Financial Results
VANCOUVER – LEEF Brands Inc. reported its strongest financial quarter since inception, showing marked operational progress and turning what had been a loss position a year ago into meaningful profitability, all without adding a single dollar of new top-line revenue. Revenue for Q1 2026 held steady at $9.4 million, matching the same period in 2025. ...
GTI Reports Q1 2026 Financial Results
CHICAGO – Green Thumb Industries Inc. released its first-quarter 2026 financial results, highlighting steady performance in a market still marked by price competition and variable demand. The multistate Cannabis operator posted steady revenue growth, alongside gains in key profitability measures, solid cash flow from operations, contributions from new store openings, and early impacts from the ...
Target Expands Hemp-Derived THC Beverage Sales Area
NEW YORK – Target is broadening its reach in the hemp-derived THC beverage category, adding the products to more than 300 stores across Florida, Texas and parts of Illinois. The mass retailer confirmed the move as a limited test, building on its earlier pilot in Minnesota. Products will appear in all stores in Florida and ...
Cannara Biotech Wraps Up Medican Organic Acquisition
MONTREAL – Cannara Biotech Inc. announced the closing of a transaction to acquire all of the shares of Medican Organic Inc. for an aggregate purchase price of $2.8 million. On the surface, that's a modest sum. In context, it's the final piece of a five-year consolidation play that Cannara has been assembling since 2021. This ...
Aprio Targets Cannabis Sector in Price Kong Acquisition
ATLANTA-PHOENIX – Aprio, the 20th largest business advisory and accounting firm in the United States, announced it had entered into an agreement to acquire Price Kong, a Phoenix-based CPA and advisory firm. The transaction, effective June 1, 2026, expands Aprio's Arizona presence and brings accounting, audit, and advisory capabilities to complement its existing footprint in ...
RYTHM Reports Q1 2026 Financial Results
ROLLING MEADOWS – RHYTHM Inc. disclosed stronger results for the first quarter of 2026 as the company continued its shift toward branded hemp-derived THC products and licensing deals. Revenue from continuing operations came in at $13.3 million, a 24% jump from $10.7 million the prior quarter, while gross profit reached $10.4 million, representing a 78% ...
High Tide Scores Big in Germany Through Remexian Distribution
CALGARY-BERLIN – High Tide Inc. reported that its majority-owned German subsidiary, Remexian Pharma GmbH, distributed 7.6 tons of medical Cannabis flower into the German market during the second fiscal quarter ended April 30, 2026 – the highest quarterly volume in the company's history since its founding in 2018. Volume increased 21% on a sequential basis ...
Curaleaf Reports Q1 2026 Financial Results
STAMFORD – Curaleaf Holdings Inc. posted its strongest revenue growth in years during the first quarter of 2026, swinging to a net profit just as the federal regulatory environment under which the industry operates began to shift in a specific, measurable way. For Q1 2026, Curaleaf reported net revenue of $324.2 million, up 6% from ...
LeafLink Releases 2026 Wholesale Cannabis Pricing Guide
NEW YORK – LeafLink, a unified B2B marketplace and technology platform built specifically for the Cannabis industry, published its annual 2026 Wholesale Cannabis Pricing Guide, delivering one of the most comprehensive data snapshots the legal Cannabis trade has produced to date. The report draws on billions of dollars in actual transactions and covers more than ...
Psilocybin Shows Promise for Those Ready to Break Free from Nicotine
BALTIMORE – Researchers at Johns Hopkins University have published findings from a pilot randomized clinical trial that points to potential advantages of psilocybin-assisted therapy over standard nicotine replacement for helping adults quit cigarettes. Published in JAMA Network Open, the study compared nicotine patches to psilocybin as smoking cessation tools. At the six-month mark, participants who ...
Hall of Flowers Relocates Northern California Event to Sacramento
LOS ANGELES – After eight years in Santa Rosa, the B2B Cannabis trade show Hall of Flowers is moving its Northern California event to the Cal Expo exhibition halls in Sacramento. The newly confirmed dates, November 4 and 5, 2026, mark the first time the show has ever staged an event in California's state capital. ...
Vireo to Acquire FLUENT in All-Stock Deal
LOS ANGELES – Vireo Growth Inc. announced it has signed a definitive agreement to absorb FLUENT Corp. in an all-stock transaction, a deal that, if approved, would make Vireo the third-largest operator in medical-only Florida's multibillion-dollar Cannabis market. Under the terms of the definitive arrangement agreement, FLUENT shareholders will receive 0.0705359 of a Vireo subordinate ...
DEA Assigns Specific Schedule I Listing and Drug Code to HHC
WASHINGTON – The Drug Enforcement Administration (DEA) has issued a final rule that formally lists hexahydrocannabinol (HHC) as a Schedule I controlled substance with its own dedicated drug code. The notice, published in the Federal Register, establishes the specific entry for the compound 6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol (HHC) in the list of Schedule I hallucinogenic substances. It assigns ...
Allied Market Research: Global Cannabis Market to Generate $149B by 2031
PORTLAND – A report recently published by Allied Market Research projects the global Cannabis market will reach $148.9 billion by 2031, up from $25.7 billion in 2021 – a nearly sixfold increase over a decade, compounding at 20.1% annually. For the industry that spent most of the 20th century in legal exile, those figures represent ...
Curaleaf Takes Full Control of Germany’s Four 20 Pharma
STAMFORD – Curaleaf Holdings Inc. closed the final chapter of a four-year German acquisition story, completing the buyout of the remaining 45% stake it did not previously own in Four 20 Pharma GmbH, a move that converts a once-minority investment into full corporate ownership. The deal traces back to August 2022, when Curaleaf first announced ...
Verano Reports Q1 2026 Financial Results
CHICAGO – Verano Holdings Corp. released its financial results for the three months ended March 31, 2026, showing revenue largely in line with recent quarters as the multi-state Cannabis operator managed wholesale pressures while leaning on its retail network. The company generated revenues net of discounts of $208.2 million in the first quarter. That figure ...
SNDL Reports Q1 2026 Financial and Operational Results
EDMONTON – SNDL Inc. disclosed a 4.4% drop in net revenue for the three months ended March 31, 2026, as softness in both its Cannabis and liquor businesses weighed on results. The company, which operates across Cannabis production, retail stores and liquor, posted net revenue of C$195.9 million in the quarter. That compared with C$204.9 ...
Hemp THC Ban Moves Closer as Congressional Fixes Collapse
WASHINGTON – The federal clock on hemp-derived THC products is ticking with no sign of relief from Capitol Hill. Amendments filed last week to delay, or in one case accelerate, the November 12 ban on most intoxicating hemp products have collapsed in the House Rules Committee, leaving a $28 billion industry without a legislative lifeline ...
Helus Pharma Teams Up with TARA Mind on Veteran Mental Health Efforts
NEW YORK – Helus Pharma, a clinical-stage biopharmaceutical company focused on developing novel serotonergic agonists (NSAs) to treat mental health conditions, announced it has joined forces with TARA Mind to help recruit veterans for its Phase 3 trial of an experimental treatment for major depressive disorder (MDD) and to broaden mental health support in military ...
Rescheduling: What it Actually Means for US Cannabis
LOS ANGELES – For years, the Cannabis industry's most reliable tradition has been misreading federal signals. When the DEA floated rescheduling proposals, operators popped champagne. When states passed adult-use laws, investors rushed in ahead of federal clarity. And last week, when Acting Attorney General Todd Blanche signed a final order reclassifying state-licensed medical Cannabis to ...
DEA Opens Federal Registration Portal for Medical Cannabis Dispensaries
WASHINGTON – The Drug Enforcement Administration (DEA) is set to launch its new online portal on Wednesday, 29 April at 9:00 AM EST, facilitating the application process for state-licensed medical Cannabis dispensaries seeking federal registration following the recent move to place certain Cannabis products into Schedule III under the Controlled Substances Act. The portal, run ...
Blind Spot: Cannabis Industry Falls Short on Communications
NEW YORK – Legal Cannabis brought in $38.5 billion in revenue in 2024. Whitney Economics estimated that figure to drop to between $29.1 billion and $29.6 billion in 2025, due to falling prices, tax pressures, and stronger competition. Sales are then forecast to recover and reach $47 billion in 2026. Despite this scale, a new ...
Cannabis 3.0 — The Body Was Designed to Heal
LOS ANGELES- The cannabis industry is entering a new phase. The first era—Cannabis 1.0—was defined by prohibition and the fight for legalization. Cannabis 2.0 followed, driven by commercialization: brands, retail expansion, and the rapid scaling of products into consumer markets. What comes next is fundamentally different. Cannabis 3.0 is not about access or scale. It ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Two weeks that rewrote the rules. That is the most accurate way to characterize what the U.S. Сannabis and Psychedelics industries have experienced heading into the final days of April 2026. Federal policy shifted in ways operators spent decades petitioning for. Consumer product categories reshuffled. Capital crossed borders. Cannabis spread into areas ...
IRS and Treasury Move to Clarify Cannabis Tax Rules
WASHINGTON – The U.S. Department of the Treasury and the Internal Revenue Service made an announcement, confirming they will issue formal guidance to address the federal tax consequences of a Department of Justice order that immediately reclassified certain Cannabis products under the Controlled Substances Act (CSA). The scope of this reclassification is deliberate and narrow. ...
